Do analysts prefer RDGT or HKPD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, RDGT or HKPD?

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.02 -$1.25M N/A N/A Hong Kong Pharma Digital Technology $13.43M 0.15 -$1.14M N/A N/A

Is RDGT or HKPD more profitable?

Company Net Margins Return on Equity Return on Assets Ridgetech N/A N/A N/A Hong Kong Pharma Digital Technology N/A N/A N/A

Do analysts recommend HKPD or MEDS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, HKPD or MEDS?

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Wellgistics Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hong Kong Pharma Digital Technology $13.43M 0.15 -$1.14M N/A N/A Wellgistics Health $23.34M 0.48 -$101.28M -$46.13 N/A

Is HKPD or MEDS more profitable?

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%. Company Net Margins Return on Equity Return on Assets Hong Kong Pharma Digital Technology N/A N/A N/A Wellgistics Health -1,100.16% N/A -171.81%

Do analysts recommend MCK or HKPD?

McKesson presently has a consensus price target of $973.44, indicating a potential upside of 12.24%. Given McKesson's stronger consensus rating and higher possible upside, equities analysts clearly believe McKesson is more favorable than Hong Kong Pharma Digital Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score McKesson 0 Sell rating(s) 4 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.78 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, MCK or HKPD?

McKesson has higher revenue and earnings than Hong Kong Pharma Digital Technology. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.25 $4.76B $37.37 23.21 Hong Kong Pharma Digital Technology $13.43M 0.15 -$1.14M N/A N/A

Do analysts rate COR or HKPD?

Cencora currently has a consensus target price of $370.85, indicating a potential upside of 19.81%. Given Cencora's stronger consensus rating and higher possible upside, analysts clearly believe Cencora is more favorable than Hong Kong Pharma Digital Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cencora 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.81 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, COR or HKPD?

Cencora has higher revenue and earnings than Hong Kong Pharma Digital Technology. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cencora $321.33B 0.18 $1.55B $13.46 23.00 Hong Kong Pharma Digital Technology $13.43M 0.15 -$1.14M N/A N/A

Do analysts prefer CAH or HKPD?

Cardinal Health currently has a consensus target price of $266.56, indicating a potential upside of 19.85%. Given Cardinal Health's stronger consensus rating and higher probable upside, analysts clearly believe Cardinal Health is more favorable than Hong Kong Pharma Digital Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardinal Health 0 Sell rating(s) 3 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.84 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, CAH or HKPD?

Cardinal Health has higher revenue and earnings than Hong Kong Pharma Digital Technology. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cardinal Health $254.25B 0.20 $1.71B $7.23 30.76 Hong Kong Pharma Digital Technology $13.43M 0.15 -$1.14M N/A N/A

Hong Kong Pharma Digital Technology (HKPD) Competitors

$0.12 +0.00 (+1.26%)

Closing price 04:00 PM Eastern

Extended Trading

$0.12 0.00 (-0.58%)

As of 07:50 PM Eastern

Compare

HKPD vs. RDGT, MEDS, MCK, COR, and CAH

Should you buy Hong Kong Pharma Digital Technology stock or one of its competitors? Hong Kong Pharma Digital Technology's main competitors and comparable companies include Ridgetech (RDGT), Wellgistics Health (MEDS), McKesson (MCK), Cencora (COR), and Cardinal Health (CAH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare distributors" industry.

How does Hong Kong Pharma Digital Technology compare to Ridgetech?

Ridgetech (NASDAQ:RDGT) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

In the previous week, Ridgetech and Ridgetech both had 1 articles in the media. Ridgetech's average media sentiment score of 0.00 equaled Hong Kong Pharma Digital Technology'saverage media sentiment score.

Company	Overall Sentiment
Ridgetech	Neutral
Hong Kong Pharma Digital Technology	Neutral

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A
Hong Kong Pharma Digital Technology	$13.43M	0.15	-$1.14M	N/A	N/A

45.3% of Ridgetech shares are held by institutional investors. 22.6% of Ridgetech shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Ridgetech has a beta of -0.08, meaning that its share price is 108% less volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.23, meaning that its share price is 123% more volatile than the broader market.

Summary

Ridgetech and Hong Kong Pharma Digital Technology tied by winning 3 of the 6 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Wellgistics Health?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Wellgistics Health (NASDAQ:MEDS) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

5.7% of Wellgistics Health shares are held by institutional investors. 29.1% of Wellgistics Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Hong Kong Pharma Digital Technology has a beta of 2.23, meaning that its stock price is 123% more volatile than the broader market. Comparatively, Wellgistics Health has a beta of -1.77, meaning that its stock price is 277% less volatile than the broader market.

In the previous week, Wellgistics Health had 7 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 8 mentions for Wellgistics Health and 1 mentions for Hong Kong Pharma Digital Technology. Hong Kong Pharma Digital Technology's average media sentiment score of 0.00 equaled Wellgistics Health'saverage media sentiment score.

Company	Overall Sentiment
Hong Kong Pharma Digital Technology	Neutral
Wellgistics Health	Neutral

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%.

Company	Net Margins	Return on Equity	Return on Assets
Hong Kong Pharma Digital Technology	N/A	N/A	N/A
Wellgistics Health	-1,100.16%	N/A	-171.81%

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Wellgistics Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hong Kong Pharma Digital Technology	$13.43M	0.15	-$1.14M	N/A	N/A
Wellgistics Health	$23.34M	0.48	-$101.28M	-$46.13	N/A

Summary

Wellgistics Health beats Hong Kong Pharma Digital Technology on 5 of the 9 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to McKesson?

McKesson (NYSE:MCK) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, risk and institutional ownership.

McKesson presently has a consensus price target of $973.44, indicating a potential upside of 12.24%. Given McKesson's stronger consensus rating and higher possible upside, equities analysts clearly believe McKesson is more favorable than Hong Kong Pharma Digital Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

McKesson has higher revenue and earnings than Hong Kong Pharma Digital Technology.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.25	$4.76B	$37.37	23.21
Hong Kong Pharma Digital Technology	$13.43M	0.15	-$1.14M	N/A	N/A

McKesson has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.23, indicating that its share price is 123% more volatile than the broader market.

85.1% of McKesson shares are held by institutional investors. 0.1% of McKesson shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, McKesson had 9 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 10 mentions for McKesson and 1 mentions for Hong Kong Pharma Digital Technology. McKesson's average media sentiment score of 0.52 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that McKesson is being referred to more favorably in the media.

Company	Overall Sentiment
McKesson	Positive
Hong Kong Pharma Digital Technology	Neutral

McKesson has a net margin of 1.12% compared to Hong Kong Pharma Digital Technology's net margin of 0.00%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

Summary

McKesson beats Hong Kong Pharma Digital Technology on 12 of the 14 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Cencora?

Cencora (NYSE:COR) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, media sentiment, valuation, analyst recommendations and profitability.

Cencora has higher revenue and earnings than Hong Kong Pharma Digital Technology.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$321.33B	0.18	$1.55B	$13.46	23.00
Hong Kong Pharma Digital Technology	$13.43M	0.15	-$1.14M	N/A	N/A

Cencora currently has a consensus target price of $370.85, indicating a potential upside of 19.81%. Given Cencora's stronger consensus rating and higher possible upside, analysts clearly believe Cencora is more favorable than Hong Kong Pharma Digital Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.81
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Cencora had 6 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 7 mentions for Cencora and 1 mentions for Hong Kong Pharma Digital Technology. Cencora's average media sentiment score of 0.78 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that Cencora is being referred to more favorably in the media.

Company	Overall Sentiment
Cencora	Positive
Hong Kong Pharma Digital Technology	Neutral

Cencora has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.23, suggesting that its stock price is 123% more volatile than the broader market.

Cencora has a net margin of 0.79% compared to Hong Kong Pharma Digital Technology's net margin of 0.00%. Cencora's return on equity of 125.45% beat Hong Kong Pharma Digital Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.79%	125.45%	4.18%
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

97.5% of Cencora shares are held by institutional investors. 0.4% of Cencora shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Cencora beats Hong Kong Pharma Digital Technology on 13 of the 14 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Cardinal Health?

Cardinal Health (NYSE:CAH) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.

Cardinal Health has a net margin of 0.67% compared to Hong Kong Pharma Digital Technology's net margin of 0.00%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardinal Health	0.67%	-98.53%	4.69%
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

Cardinal Health has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.23, meaning that its share price is 123% more volatile than the broader market.

87.2% of Cardinal Health shares are owned by institutional investors. 0.1% of Cardinal Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Cardinal Health currently has a consensus target price of $266.56, indicating a potential upside of 19.85%. Given Cardinal Health's stronger consensus rating and higher probable upside, analysts clearly believe Cardinal Health is more favorable than Hong Kong Pharma Digital Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardinal Health	0 Sell rating(s)	3 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.84
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cardinal Health has higher revenue and earnings than Hong Kong Pharma Digital Technology.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardinal Health	$254.25B	0.20	$1.71B	$7.23	30.76
Hong Kong Pharma Digital Technology	$13.43M	0.15	-$1.14M	N/A	N/A

In the previous week, Cardinal Health had 8 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 9 mentions for Cardinal Health and 1 mentions for Hong Kong Pharma Digital Technology. Cardinal Health's average media sentiment score of 0.98 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that Cardinal Health is being referred to more favorably in the media.

Company	Overall Sentiment
Cardinal Health	Positive
Hong Kong Pharma Digital Technology	Neutral

Summary

Cardinal Health beats Hong Kong Pharma Digital Technology on 12 of the 14 factors compared between the two stocks.

Get Hong Kong Pharma Digital Technology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HKPD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HKPD vs. The Competition

Export

Metric	Hong Kong Pharma Digital Technology	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.95M	$9.74B	$7.32B	$13.29B
Dividend Yield	N/A	2.59%	2.52%	12.57%
P/E Ratio	N/A	34.16	274.40	25.76
Price / Sales	0.15	4.96	639.25	86.81
Price / Cash	N/A	122.11	77.80	52.76
Price / Book	0.20	5.19	10.52	6.34
Net Income	-$1.14M	$315.70M	$3.49B	$360.00M
7 Day Performance	-1.31%	-1.94%	-1.08%	-0.11%
1 Month Performance	-67.55%	-2.33%	-3.39%	-3.42%
1 Year Performance	-92.21%	12.96%	15.08%	5.46%

Hong Kong Pharma Digital Technology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HKPD Hong Kong Pharma Digital Technology	0.6678 of 5 stars	$0.12 +1.3%	N/A	-91.8%	$1.95M	$13.43M	N/A	11	Gap Up
RDGT Ridgetech	1.1131 of 5 stars	$0.83 flat	N/A	-99.5%	$3.01M	$132.16M	N/A	980	Positive News
MEDS Wellgistics Health	0.1409 of 5 stars	$0.90 flat	N/A	-92.5%	$2.88M	$23.34M	N/A	31	Analyst Forecast Short Interest Increase Gap Up
MCK McKesson	4.4408 of 5 stars	$880.52 -0.1%	$973.44 +10.6%	+19.4%	$102.66B	$403.43B	23.56	43,000	Trending News
COR Cencora	4.8659 of 5 stars	$321.44 0.0%	$370.85 +15.4%	+3.3%	$61.34B	$321.33B	23.88	51,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HKPD) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hong Kong Pharma Digital Technology (HKPD) Competitors

HKPD vs. RDGT, MEDS, MCK, COR, and CAH

How does Hong Kong Pharma Digital Technology compare to Ridgetech?

Summary

How does Hong Kong Pharma Digital Technology compare to Wellgistics Health?

Summary

How does Hong Kong Pharma Digital Technology compare to McKesson?

Summary

How does Hong Kong Pharma Digital Technology compare to Cencora?

Summary

How does Hong Kong Pharma Digital Technology compare to Cardinal Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HKPD vs. The Competition

Hong Kong Pharma Digital Technology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hong Kong Pharma Digital Technology (HKPD) Competitors

HKPD vs. RDGT, MEDS, MCK, COR, and CAH

How does Hong Kong Pharma Digital Technology compare to Ridgetech?

Is RDGT or HKPD more profitable?

Does the media favor RDGT or HKPD?

Which has stronger earnings & valuation, RDGT or HKPD?

Do insiders and institutionals believe in RDGT or HKPD?

Do analysts prefer RDGT or HKPD?

Which has more risk and volatility, RDGT or HKPD?

Summary

How does Hong Kong Pharma Digital Technology compare to Wellgistics Health?

Do analysts recommend HKPD or MEDS?

Do insiders & institutionals hold more shares of HKPD or MEDS?

Which has more volatility & risk, HKPD or MEDS?

Does the media refer more to HKPD or MEDS?

Is HKPD or MEDS more profitable?

Which has preferable earnings and valuation, HKPD or MEDS?

Summary

How does Hong Kong Pharma Digital Technology compare to McKesson?

Do analysts recommend MCK or HKPD?

Which has higher earnings and valuation, MCK or HKPD?

Which has more volatility and risk, MCK or HKPD?

Do insiders and institutionals have more ownership in MCK or HKPD?

Does the media favor MCK or HKPD?

Is MCK or HKPD more profitable?

Summary

How does Hong Kong Pharma Digital Technology compare to Cencora?

Which has higher valuation & earnings, COR or HKPD?

Do analysts rate COR or HKPD?

Does the media prefer COR or HKPD?

Which has more volatility and risk, COR or HKPD?

Is COR or HKPD more profitable?

Do insiders & institutionals have more ownership in COR or HKPD?

Summary

How does Hong Kong Pharma Digital Technology compare to Cardinal Health?

Is CAH or HKPD more profitable?

Which has more risk and volatility, CAH or HKPD?

Do institutionals and insiders believe in CAH or HKPD?

Do analysts prefer CAH or HKPD?

Which has preferable earnings & valuation, CAH or HKPD?

Does the media prefer CAH or HKPD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HKPD vs. The Competition

Hong Kong Pharma Digital Technology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools